Form 4 for PRLB Proto Labs Inc
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0001628280-25-008704 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-27 | 2025-02-25 | PRLB | Kenison Michael R. | Chief Ops Off | A - Grant | $0.00 | +6,943 | 29.0K | +32% | $0 |
| D | 2025-02-27 | 2025-02-25 | PRLB | Kenison Michael R. | Chief Ops Off | A - Grant | $0.00 | +6,231 | 6,231 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | A | A | 6,943 | $0.00 | 28,982 | D | — | — | (F1) Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-02-25 | A | A | 6,231 | $0.00 | 6,231 | D | $39.61 · — to 2035-02-25 | 6,231 Common Stock | (F2) 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. |